Cite
HARVARD Citation
Chugh, R. et al. (2021). SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma. Cancer. 127 (8), pp. 1301-1310. [Online].